International PFO Consortium

NCT00859885 · clinicaltrials.gov ↗

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Stroke
Transient Ischemic Attack

Interventions

DRUG: Antithrombotic treatment
DEVICE: percutaneous device closure of PFO

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]